Resource Hub
The Prompt Problem: Why Uncontrolled AI Inputs Are a Compliance Risk
When AI Inputs Become a Compliance Liability When organisations evaluate AI tools, the conversation usually centres on model capability: accuracy, speed, hallucination rates. These matter. But they overlook a more operationally critical question: who controls the prompt? In generic AI platforms, prompt creation is left entirely to individual users. Everyone
Eliminating the AI “Black Box”: Traceability and Auditability
One of the most common concerns about AI in regulated environments is traceability. If AI generates an answer, how was it derived? What sources were evaluated? Can the process be audited? Many AI tools provide outputs without source visibility. This creates a “black box” scenario — unacceptable in regulatory contexts.
Security and Privacy in AI: A Regulatory Imperative
Security and Privacy in AI: A Regulatory Imperative Security is often discussed in AI conversations, but in regulated industries, it is non-negotiable.Many generic AI integrations operate through system-level access. An LLM may interact with data using elevated permissions that do not reflect individual user rights. In some models, content is
Built-In vs Bolted-On AI: Why Architecture Matters in Life Sciences
Built-In vs Bolted-On AI: Why Architecture Matters in Life Sciences From Copilot-style assistants to generic AI overlays, many platforms now claim to have ‘groundbreaking’ AI capabilities. But for life sciences organisations operating in highly regulated environments, the real question is not whether AI exists, but whether it has the correct
CARA AI for Clinical, Transforming Clinical Authoring with Faster, More Consistent Workflows
Transforming Pharmacovigilance Efficiency Through CARA AI for Safety CARA AI for Safety, our native intelligence layer built directly into the CARA Life Sciences Platform, enables a 50–70% reduction in drafting time per cycle for PBRERs and DSURs, supporting faster development of PBRERs, DSURs, and RMPs with consistent safety narratives across
CARA AI for Safety, Enhancing Speed, Consistency, and Risk Visibility
CARA AI, Optimising End‑to‑End Clinical Documentation for Greater Impact CARA AI for Safety, our native intelligence layer built directly into the CARA Life Sciences Platform, enables a 50–70% reduction in drafting time per cycle for PBRERs and DSURs, supporting faster development of PBRERs, DSURs, and RMPs with consistent safety narratives
CARA AI for Regulatory, the intelligence layer you’ve been missing
Enhancing Regulatory Efficiency Through Proactive Lifecycle Management Your team is brilliant. Imagine what they could do if they weren’t buried in document and data manual cross- checks. CARA AI enables A 70% reduction in authoring time for Module 2 summary documents enables faster submissions, fewer rework cycles, and sustained global alignment
8 Reasons Why Generic AI Systems are Not Suitable for Life Sciences Companies
Unlike some other industries, the risks of using generic AI are much higher in Life Sciences due to stringent regulations and rules around data and information processing. See how you can avoid the common pitfalls of choosing generic AI and what you should require instead Avoid limited Siloed AI Capabilities
CARA AI for Quality, Intelligent Quality Management, Built In
For Quality teams, CARA AI replaces manual firefighting and fragile traceability with predictive oversight, consistent documentation, and audit-ready control, while removing the time and risk created by manual QMS processes. With CARA AI for Quality Predictive oversight instead of firefightingEmerging risks are surfaced early from deviations, complaints, and audits. Dramatically
